Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity
Clicks: 293
ID: 269109
2011
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
293 views
45 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #17 of 23 articles by views in international journal of antimicrobial agents
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Antibiotic therapy improves the outcome of severe sepsis and septic shock, however pharmacokinetic properties are altered in this scenario. Amikacin (AMK) is an option to treat community or nosocomial infections, although standard doses might be insufficient in critically ill patients. The aim of th …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (44 words).
Try re-searching for a better abstract.
| Reference Key |
r2011internationalhigher
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Gálvez R;Luengo C;Cornejo R;Kosche J;Romero C;Tobar E;Illanes V;Llanos O;Castro J;; |
| Journal | international journal of antimicrobial agents |
| Year | 2011 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
male
aged
middle aged
Randomized Controlled Trial
sepsis / drug therapy*
anti-bacterial agents / administration & dosage*
anti-bacterial agents / pharmacokinetics
amikacin / adverse effects*
anti-bacterial agents / adverse effects*
amikacin / administration & dosage*
kidney function tests
pmid:21612894
doi:10.1016/j.ijantimicag.2011.03.022
ricardo gálvez
cecilia luengo
josé castro
amikacin / pharmacokinetics
creatinine / metabolism
metabolic clearance rate
plasma / chemistry*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.